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The impact of appointments timed in proximity to annual
milestones on compliance with screening: randomised
controlled trial
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ABSTRACT
Objective To investigate whether appointments for
screening timed in proximity to annual milestones
(birthdays, Christmas and New Year) may be used as a
strategytoimproveattendanceforscreeningforcolorectal
cancer.
Design Randomised controlled trial.
Setting City of Oslo (urban) and Telemark county (urban
and rural), Norway.
Participants 12960 screened adults (64.7% of those
invited).
Main outcome measure Attendance rates for each week
and month of assigned appointment.
Results Attendance rates were significantly higher in
December than the rest of the year (72.3% v 64.6%,
P<0.001) in adults who received an invitation in the week
of their birthday or were assigned to screening in the first
or second week after their birthday (67.9% v 64.5%,
P=0.007). This effect was most pronounced in the urban
population of Oslo. In a multivariable logistic regression
model, attendance improved in those who received an
invitationintheweekoftheirbirthdayorwereassignedto
screening in the first or second week after their birthday
(odds ratio 1.15, 95% confidence interval 1.03 to 1.28)
and those who were assigned to screening in December
(odds ratio 1.45, 1.16 to 1.82).
Conclusion Attendance rates for screening for colorectal
cancer were higher in December and around attendees’
birthdays, the latter particularly in an urban population.
Compliancewithscreeningprogrammesmaythereforebe
improved by timing invitations in proximity to annual
milestones.
Trial registration Clinical Trials NCT00119912.
INTRODUCTION
Colorectal cancer is the third most incident cancer
worldwide, with more than 1 million new cases
detected every year.
1 At least 75% of these cases are
sporadic, with age as the main risk factor. Although
severalbarriershave been identifiedas contributing to
low attendance for screening,
23 age as a motivating
factor has not been assessed. In a small study of
screeningusingflexiblesigmoidoscopy,thelocalpress
highlighted age as a risk factor for colorectal cancer at
the time the invitations were posted. Invitees were
given an appointment for screening within weeks after
their birthday. This study, Telemark Polyp Study 1
(TPS-1),achievedanattendancerateof81%,
4butitwas
uncertainifthetimingofinvitationswasimportantand
if this strategy was worth adopting in screening
programmes with poor attendance. The recently
implemented national screening programme for
bowel cancer in Australia aims to invite adults for
screeningwithintwoorthreemonthsoftheirbirthday,
5
butthisisforpracticalreasonsandnotastrategychosen
to improve attendance (Graeme Young, personal
communication, 2008).
In a large study of screening for colorectal cancer
using flexible sigmoidoscopy carried out in Norway
during 1999-2001,
6 appointments were randomly
allocated to 20780 adults throughout the three year
screening period. We investigated whether invitations
timed in proximity to annual milestones (birthdays,
Christmas and New Year) had an impact on compli-
ance with screening.
METHODS
The Norwegian Colorectal Cancer Prevention Trial 1
(NORCCAP-1) is a randomised controlled trial of
flexible sigmoidoscopy or flexible sigmoidoscopy
combined with faecal occult blood testing as screening
modalities. Details of the study are published
elsewhere.
7 Briefly, 20780 adults (male to female
ratio 1:1) aged 50-64 were randomly identified from
the population registries of the City of Oslo (urban
area) and Telemark county (urban and rural areas),
Norway and invited to screening. Invitations were
posted six or seven weeks before the assigned
appointment. The population in the screening areas is
predominantly ethnic Norwegian. The remaining
relevant age cohorts in the screening areas constituted
the control group (n=79430), who were not invited to
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mised participants in the intervention arm (1:1) to
once only screening with flexible sigmoidoscopy or to
flexiblesigmoidoscopywithfaecaloccultbloodtesting.
The proposed dates for appointment were randomly
allocated on an individual basis by a computerised
procedure developed for the study. In total, 777 adults
were excluded after randomisation to the screening
group but before screening, according to defined
criteria.
6 The participants gave written informed
consent to take part in the study. The end points of
the study were incidence of and death from colorectal
cancer. The present study on attendance in relation to
annualmilestoneswasnotaprespecifiedanalysisofthe
trial.
We calculated the distribution of screening appoint-
ments according to birth month of those invited to
screeningandusedtheχ
2testforstatisticalsignificance.
To determine variables that contributed to attendance
weusedlogisticregressionanalyses.Wefirsttestedthe
variables of interest (age, sex, screening modality,
centre, time of appointment, and time of appointment
in relation to birthday) in univariable analyses, and
then incorporated these in a multivariable model. The
association between the variables and attendance was
expressedas odds ratioswith 95% confidence interval.
We used SPSS version 14.0 for analyses.
RESULTS
Overall, 12960 of 20003 invited adults (64.7%)
attended screening for colorectal cancer. Attendance
was higher for women than for men (66.0% v 63.5%,
P<0.001)andhigherinTelemarkthaninOslo(71.4%v
58.0%,P<0.001;table 1).Higherattendancerateswere
observed with increasing age (table 1). In both sexes a
higher attendance rate was seen with increasing age—
61.6% (age 50-54), 66.4% (age 55-59), and 66.8% (age
60-64; P<0.001). The attendance rate for adults with a
50year,55year,or60yearanniversaryintheiryearof
screening was similar to that of other participants,
irrespective of sex.
With the exception of January, February, and
March, random allocation achieved a similar distribu-
tionforscreeningmonthirrespectiveofmonthofbirth.
Weekly attendance rates showed peaks in the first
and second weeks and sixth and seventh weeks after
birthdays; the sixth and seventh weeks after birthdays
corresponding to receipt of invitations in the week of a
birthday. Overall, 1095 of 1613 (67.9%) participants
whohadbeenassignedtoscreeninginthefirst,second,
sixth, and seventh weeks after birthdays attended for
screeningcomparedwith11866of18390(64.5%)who
had been assigned to screening in any other week
(P=0.007). In a subgroup analysis this difference was
statistically significant in the Oslo population, where
62.0% (482/778) of participants attended screening
appointments in the first, second, sixth, and seventh
weeks after birthdays compared with 57.7% (5255/
9105) in any other week (P=0.02). For Telemark, the
correspondingvalueswere73.4%and71.2%(P=0.17).
Attendance according to calendar month was
significantly different, with 72.3% attendance in
December as the highest and 62.5% in March as the
lowest (table 2). In Oslo, attendance in December
comparedwiththerestoftheyearwas66.8%(181/271)
v 57.8% (5556/9612; P=0.003) and in Telemark it was
79.3%(169/213)v71.2%(7055/9907;P=0.009),giving
a difference of 72.3% compared with 64.6% for Oslo
and Telemark combined (P<0.001).
Amultiplelogisticregressionanalysisconfirmedthe
univariableanalyses,withasignificantimprovementin
attendance shown in December (adjusted odds ratio
1.45, 95% confidence interval 1.16 to 1.82, P=0.001;
table 2).Similarly,invitationstimedinproximitytothe
recipients’ birthday had an independent influence on
attendance rates. The adjusted odds ratio for atten-
dance when given an appointment for screening in the
first, second, sixth, or seventh weeks after a birthday
compared with any other week was 1.15 (95%
confidenceinterval1.03to1.28;P=0.01).Independent
predictors of attendance were age, female sex, screen-
ing modality, and geographical area of residence
(table 2).
DISCUSSION
Compliance with screening for colorectal cancer in
Norwaywassignificantlyincreasedinadultsinvitedfor
screening in December and close to their birthday. To
Table 1 |Attendanceratesforcolorectalcancerscreeningusingflexiblesigmoidoscopy(FS)aloneorcombinedwithfaecaloccult
blood testing in Norway
Variable
Men Women
No invited to
screening No screened
Attendance rate
(%)
No invited to
screening No screened
Attendance rate
(%)
Total 9916 6299 63.5 10 086 6661 66.0
Oslo 4914 2825 57.5 4968 2911 58.6
Telemark 5002 3474 69.5 5117 3749 73.3
Age group (years):
50-54 3587 2161 60.2 3564 2246 63.0
55-59 3914 2573 65.7 3893 2611 67.1
60-64 2415 1565 64.8 2629 1804 68.6
FS alone 4970 3256 65.5 5042 3438 68.2
FS with faecal occult
blood testing
4946 3043 61.5 5044 3223 63.9
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timing of invitations and the effect on attendance for
screening. Invitations to screening at particular times
may improve compliance with screening and thus the
effectiveness of screening for prevention and early
detection of the target disease. Perception of ageing
may be the key factor, but other mechanisms such as
“housekeeping business” or simply “getting things
done” before annual milestones may also be consid-
ered as explanations for the observed difference in
attendance.
Strengths and limitations
Thestrengthofthisstudyisitslargesizeandpopulation
based design supporting good validity of the results. A
weakness is the generalisability of the findingsto other
countries, as the Norwegian population studied may
differ from other screening populations. Furthermore,
appointment times in December were limited to the
first two weeks of this month owing to closure for the
holiday period. Invitations for any other month were
scheduledforallweeks.Thismaypotentiallyintroduce
bias. However, when attendance in December was
analysed with the first and second weeks in any other
month, attendance still remained high (data not
shown). Thus, bias seems unlikely as a result of
differences in available appointments in December
compared with other months. In the Norwegian
national health insurance system, eligibility and pay-
mentfor screeningdo notdepend onageor the timing
ofthetestinrelationtoinsurancecoverageorprevious
screeningexaminations.Sincethepresentanalysiswas
not prespecified, the results should be considered as
generating a hypothesis rather than as definitive. The
identification and reduction of barriers to cancer
screeningisonewaytoimproveattendance,
23another
is to try to identify factors that have been successful in
trials with high attendance rates. Both the small
Telemark Polyp Study 1 and the more recent large
version of this study using flexible sigmoidoscopy had
high attendance rates in Telemark (81% and 71%). For
colorectal cancer screening using flexible sigmoido-
scopy these attendance rates are exceptionally high
comparedwiththepopulationcoverageinsimilartrials
in the United Kingdom (39%) and Italy (26%)
89and in
Swedish and Danish trials (30-47%).
1011 Whereas the
Telemark Polyp Study 1 used invitations timed near
birthdays, the Norwegian Colorectal Cancer
Table 2 |Logistic regression with odds ratio for attendance at screening for colorectal cancer in Norway
Variable No of examinations Attendance rate (%)
Crude odds ratio
(95% CI)
Adjusted odds ratio*
(95% CI) P value
Age 20 003 1.03 (0.02 to 1.03) 1.02 (1.02 to 1.03) <0.001
Men 9917 63.5 Reference —
Women 10 086 66.0 1.12 (1.05 to 1.18) 1.11 (1.05 to 1.18) <0.001
Screening group:
FS 10 013 66.9 Reference —
FS with faecal occult
blood testing
9990 62.7 0.83 (0.79 to 0.88) 0.82 (0.77 to 0.87) <0.001
Place of residence:
Oslo 9883 58.0 Reference —
Telemark 10 120 71.4 1.80 (1.70 to 1.91) 1.81 (1.71 to 1.92) <0.001
Screening weeks related
to birthday:
Any but weeks 1, 2, 6,
and 7 after birthday†
18 390 64.5 Reference —
1, 2, 6, or 7 after
birthday†
1613 67.9 1.16 (1.04 to 1.30) 1.15 (1.03 to 1.28) 0.01
Month of screening‡:
January 2012 65.7 Reference —
February 2028 65.1 0.98 (0.86 to 1.11) 1.00 (0.87 to 1.14) 0.95
March 1915 62.5 0.87 (0.76 to 0.99) 0.88 (0.77 to 1.00) 0.06
April 1452 63.7 0.92 (0.80 to 1.06) 0.96 (0.83 to 1.11) 0.57
May 1857 66.1 1.02 (0.89 to 1.16) 1.07 (0.93 to 1.23) 0.33
June 1502 63.6 0.91 (0.79 to 1.05) 0.95 (0.82 to 1.09) 0.47
August 2129 63.6 0.91 (0.80 to 1.03) 0.92 (0.81 to 1.04) 0.19
September 2282 65.8 1.00 (0.88 to 1.14) 1.01 (0.89 to 1.14) 0.93
October 2224 65.2 0.98 (0.86 to 1.11) 1.01 (0.89 to 1.15) 0.86
November 2118 64.1 0.93 (0.82 to 1.06) 0.98 (0.86 to 1.11) 0.74
December 484 72.3 1.36 (1.10 to 1.70) 1.45 (1.16 to 1.82) 0.001
FS=flexible sigmoidoscopy.
*Adjusted for age, sex, screening modality, screening centre, allotted time for screening in weeks 1, 2, 6, or 7 after birthday and month for allotted
screening appointment.
†Weeks 6 and 7 for screening appointment correspond to invitations received in birthday week.
‡P=0.009 (χ
2) for attendance in January to December. No screening in July because of summer holidays.
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the calendar year, without taking birthdays into
account.
In the present study we explored whether there
might be potential for timed invitations to improve
attendance at screening, and we focused on annual
milestones. Two annual events that are poignant
reminders of ageing are birthdays and Christmas and
NewYear.Wedidnotmentionageasariskfactorinthe
invitations, so the distribution of attendance rates in
relation to birthdays suggests that appointments
allocated shortly after birthdays or invitations timed
for receipt in the week of a birthday have the potential
toimprovecompliancewithscreening.Thestatistically
significant higher attendance in December has limited
practical implications. Screening programmes might,
however, improve attendance by increasing their
activity in December (for example, by running extra
hours).
Attendance rates in Norwegian screening studies and
timing of invitations
In contrast to the Telemark Polyp Study 1, the
Norwegian Colorectal Cancer Prevention Trial 1 did
not emphasise age as a risk factor in its invitations or
through the media in either Oslo or Telemark. The
higher attendance in Oslo when a screening appoint-
ment was given in the first or second week after a
birthday or when the invitation was received in the
week of a birthday is most likely due to inherent
differences between an urban population (Oslo) and a
mixed urban and rural population (Telemark). The
findings suggest a greater potential for using age or
annual milestones to improve attendance in an urban
population but that to achieve high attendance in
Telemark,inboththeTelemarkPolypStudy1andthe
Norwegian Colorectal Cancer Prevention Trial 1,
factors must be sought elsewhere. Plausible explana-
tions, although speculative, might be that those
responsible for both these trials in Telemark have
built up a good reputation for painless, unsedated
flexible sigmoidoscopy and colonoscopies, good com-
munication on this topic with local doctors who also
provided advice on screening to their patients, and
success in generating a public understanding that
participation carries a potential benefit to personal
health.Anotherreasonforhighattendanceforflexible
sigmoidoscopy in Norwegian trials may be that bowel
cleansing is not required before an appointment as
cleansing is by sorbitol enema administered at the
screening centre on attendance.
Using age perception in active campaigning
Although increased self awareness of age may be
inherently connected to annual milestones such as
birthdays and Christmas and New Year, it cannot be
taken for granted that a campaign to reinforce this
message will improve attendance. In an Australian
randomised study, framed messages on the risk,
generalised risk, and relative risk of colorectal cancer
failedtoincreaseparticipationrates,butthesemessages
were not specified.
12 Reactions to information on risk
factors are multifaceted when culture, context, and
presentationarebutsomeofthekeyelements.Ashigh
attendance is a prerequisite for the success of any
screening programme, most countries implementing
screening need to engage in studies on achieving high
attendance rates. One strategy could be to routinely
invite those eligible for screening to an appointment
within one or two weeks after their birthday. Any
running screening programme could easily test if the
suggestedstrategytoimproveattendancemayapplyto
their target groups. This can be done by randomly
invitingpeople to screeningin the first or secondweek
after their birthday compared with any other week.
Effect of small percentage variations in attendance
Birthdayrelatedscreeningappointmentsforcolorectal
cancer were associated with a 4.3% increase in
attendance in Oslo and a 2.2% increase in Telemark.
By allocating appointments in December the corre-
sponding gain in attendance was 9.0% and 8.1%,
respectively. What this may imply for a screening
programme in terms of ultimate intention to treat
analyses on incidence of colorectal cancer and
mortality reduction may depend on the attendance
rate (low, medium, high).
13 On a scale of 0-100% for
attendance,alowattendanceratewillprobablyinclude
a high proportion of adults at high risk of colorectal
cancerbecauseofapredispositioninthefamily,ahigh
attendanceratemightincludethemorereluctantadults
athighriskbecauseoftheirlifestyle,andbetweenthese
twowillbeadultsatlowrisk.Thus,thegainsandlosses
in diagnosis by differences in attendance rates may
vary considerably between programmes and popula-
tions,emphasisingtheneedformoreresearchonthese
variations and the ways that attendance might be
improved. In the Norwegian Colorectal Cancer
Prevention Trial 1, the addition of faecal occult blood
testing to screening using flexible sigmoidoscopy
resulted in a 4% drop in attendance, from 67% to
63%. In an intention to diagnose analysis of diagnostic
gain this drop could not be compensated by a
presumed higher sensitivity of the flexible sigmoido-
copy combined with faecal occult blood testing.
6
Therefore a change in attendance rate of 3% or 4%
either way may be of importance.
Generalisability of results
Ithasbeenarguedthathighattendanceratesintrialsof
screening for colorectal cancer in Norway may be
cultural and not easily comparable to other countries.
Attendance rates for faecal occult blood testing have
ranged from 52% in France to 67% in Denmark.
14-16
The only trial of screening using faecal occult blood
testing in Norway, at the time when 81% attendance
was obtained for flexible sigmoidoscopy in the Tele-
mark Polyp Study 1, had a compliance of 55%
17;
comparable to observations in other trials of faecal
occult blood testing. This suggests that providers of
screeningprogrammesinNorwayfacesimilarbarriers
and facilitators for screening as other countries.
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analysisofthematerialfromtheNorwegianColorectal
CancerPreventionTrial1showedthatage,femalesex,
flexible sigmoidoscopy alone, and area of residence
(Telemark in this study) remained independent deter-
minantsofattendance.Thesevariablesareknowntobe
predictors of compliance with screening,
8101118 thus
strengthening the validity of the present findings.
Conclusion
Within the present age range of 50-64 years in the
Norwegian Colorectal Cancer Prevention Trial 1
attendance increased with age. Also, attendance was
higherforthosereceivinganinvitationforscreeningin
the weekof theirbirthdayor givenan appointmentfor
screeninginthefirstorsecondweekaftertheirbirthday
—an effect that seemed statistically significant only to
the urban population of Oslo. A higher attendance in
December was observed in both populations. There
might be a potential for improving compliance with
screening programmes by playing on perception of
ages or annual milestones. We suggest that screening
programmes should consider the potential benefits of
timingappointmentsforscreeninginthefirstorsecond
weeks after birthdays and extending working hours in
December.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
Poorcompliancewithcancerscreeningisamainbarriertosuccessfulscreeningprogrammes
Adequate measures to improve compliance of the target population are difficult to identify
Age is a major risk factor for colorectal cancer and studies have consistently shown that
compliance with screening increases with age
WHAT THIS STUDY ADDS
Compliancewithscreeningcanbeimprovedbytimingappointmentsclosetobirthdaysandin
December
Althoughthereasonsforthisareuncleartheymightrelatetoremindersofageingtriggeredby
annual milestones such as birthdays
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